These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1800705)

  • 21. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
    Presnov MA; Konovalova AL
    Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs.
    Warnecke A; Fichtner I; Garmann D; Jaehde U; Kratz F
    Bioconjug Chem; 2004; 15(6):1349-59. PubMed ID: 15546202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
    Inoue S; Mizuno S; Ito M; Ohnuma T
    Jpn J Cancer Res; 1992 Nov; 83(11):1231-40. PubMed ID: 1483936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reaction of (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) with guanosine.
    Itoh M; Murata H; Honda M; Watanabe Y; Ochi K
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2825-7. PubMed ID: 2611943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DN604: A platinum(II) drug candidate with classic SAR can induce apoptosis via suppressing CK2-mediated p-cdc25C subcellular localization in cancer cells.
    Chen F; Jin X; Zhao J; Gou S
    Exp Cell Res; 2018 Mar; 364(1):68-83. PubMed ID: 29397071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato) platinum (II) monohydrate with DNA as determined by a nitrocellulose filter binding assay].
    Matsumoto T; Akamatsu K; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):253-5. PubMed ID: 1736839
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
    Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
    Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).
    Akaboshi M; Kawai K; Ujeno Y; Takada S; Miyahara T
    Jpn J Cancer Res; 1994 Jan; 85(1):106-11. PubMed ID: 7508903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
    Fujiwara Y; Nakamura M; Yokoo S
    Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.
    Theriault RL; Walters RS; Holmes FA; Esparza-Guerra L; Kowal C; Hortobagyi GN
    Cancer Chemother Pharmacol; 1996; 38(3):289-91. PubMed ID: 8646805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid.
    Almotairy ARZ; Gandin V; Morrison L; Marzano C; Montagner D; Erxleben A
    J Inorg Biochem; 2017 Dec; 177():1-7. PubMed ID: 28918353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.